Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, UTHealth
The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) is a stand-alone research institute and a key component of The University of Texas Health Science Center at Houston (UTHealth Houston), situated within the Texas Medical Center. Established in 1995, its fundamental mission is to deliver translational outcomes from research in molecular medicine that directly benefit patients and public health. The IMM is dedicated to studying and preventing human diseases at their most basic levels: the genetic, cellular, and molecular scale, utilizing advanced methodologies such as DNA and protein technologies and sophisticated animal models. The institute's work represents the critical bridge between fundamental laboratory science and clinical applications, with the executive goal of curing diseases of our time in our time.
Continue…Core Activities and Research Focus
The primary function of the IMM is to conduct cutting-edge, interdisciplinary biomedical research. The institute is organized into several specialized Research Centers, each concentrating on a major area of human disease. These centers foster collaboration among senior investigators and their associates, ensuring a thematic and cohesive approach to complex medical problems.
Research Centers (Thematic Programs and Areas of Study)
The foundational work of the IMM is executed through its operational research centers, which include:
- Center for Cardiovascular Genetic Research: Focused on identifying genetic variants that contribute to cardiovascular disease risk, including heart attack and stroke.
- Center for Human Genetics: Dedicated to the study of the human genome to understand the genetic basis of disease susceptibility and resistance.
- Center for Metabolic and Degenerative Diseases: Investigating disorders such as diabetes and conditions linked to excessive fat accumulation, including the relationship between obesity and cancer.
- Center for Molecular Imaging: Advancing technology for non-invasive imaging, including pioneering work on first-in-human images of near-infrared fluorescence.
- Center for Neuroimmunology and Glial Biology: Concentrating on the interplay between the nervous and immune systems and the role of glial cells in neurological health and disease.
- Senator Lloyd Bentsen and B.A. Bentsen Center for Stroke Research: A specialized center for the investigation and development of preventive and therapeutic strategies for stroke.
- Texas Therapeutics Institute: Operating as a multi-institutional collaboration that actively encourages and conducts small molecule, antibody, and aptamer drug discovery programs.
- Center for Translational Cancer Research: Working to translate basic research findings into new treatment and prevention strategies for various forms of cancer, including research on nanomedicine applications.
Key Research and Therapeutic Programs
Beyond the scope of the individual centers, the IMM???s current research portfolio includes specific, high-impact projects that represent the institute???s core ???products??? of discovery and intellectual property:
- Drug Discovery: Active programs in antibody, aptamer, and small molecule drug discovery are a primary focus, often in collaboration with the Texas Therapeutics Institute.
- Stem Cell Applications: Research into the properties and therapeutic applications of both adult and embryonic stem cells for regenerative medicine.
- Cancer and Metabolic Disease: Ongoing studies on the links between obesity, excessive fat accumulation, diabetes, and various cancers, as well as the application of proteomics and systems biology to cancer and immunology.
- Nanomedicine: The development and application of nanomedicine techniques for targeted treatment in cancer and infectious diseases.
- Genetic Discovery: Identification and characterization of genetic variants associated with increased risk for common, complex diseases.
Products and Services (Core Facilities and Resources)
As a major research institution, the IMM provides specialized core facilities and services that support its own scientists and are often made available to external academic and industry collaborators, acting as essential technical "services" to the biotech and life sciences community.
Service Centers and Core Facilities
The Institute operates several high-tech core facilities to facilitate advanced molecular research:
- Clinical and Translational Proteomics Service Center: Provides expertise and instrumentation for large-scale protein analysis, critical for identifying biomarkers and therapeutic targets.
- Center for Advanced Microscopy: Offers state-of-the-art imaging technologies and expertise, crucial for visualizing cellular and molecular processes.
- Flow Cytometry Services: Provides sophisticated cell analysis and sorting capabilities for immunology and cell biology research.
- Biopharmaceutical Discovery Cores: These include the Antibody Drug Discovery Core and the Antibody Engineering and Expression Core, which provide resources and technical support for the creation and optimization of biological therapeutic agents.
- DNA Core Module: A foundational facility providing services related to nucleic acid analysis and manipulation, including genotyping and real-time quantitative PCR (qPCR) support for research projects.
Through its extensive research infrastructure, dedicated scientific staff, and targeted research centers, the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, UTHealth, serves as a major engine for translational medicine, actively pursuing fundamental discoveries and developing pre-clinical therapeutic strategies for significant human diseases.
